Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis?

被引:68
作者
dePablo, A [1 ]
Villena, V [1 ]
EchaveSustaeta, J [1 ]
Encuentra, AL [1 ]
机构
[1] UNIV MADRID, HOSP 12 OCTUBRE, RESP DIS SERV, MADRID 28041, SPAIN
关键词
lysozyme; pleural inflammation; pleural thickening; pleural tuberculosis; tumor necrosis factor-alpha;
D O I
10.1378/chest.112.5.1293
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: Identification of predictive factors for the development of r Design: Retrospective study. Location: A 1,500-bed tertiary hospital. Patients: Patients with pleural tuberculosis diagnosed between December 1991 and February 1995 in our Respiratory Disease Service. Interventions: The clinical and radiologic characteristics, and measurements of microbiological and biochemical parameters and markers in pleural fluid were studied. RPT was defined in a posteroanterior chest radiograph as a pleural space of >2 mm measured in the lower lateral chest at the level of an imaginary line intersecting the diaphragmatic dome. Measurements and results: In 56 patients studied, 11 (19.6%) had RPT 10 mm and 24 (42.8%) had RPT > 2 mm. The pleural fluid of patients with RPT 10 mm had a significantly lower glucose concentration and pH and higher lysozyme and tumor necrosis factor-or levels than the other patients. The pleural fluid of patients with RPT >2 mm showed no significant differences. Conclusions: The development of RPT 10 mm was related to higher concentrations of lysozyme and tumor necrosis factor-alpha and lower glucose concentration and pH in pleural fluid compared with development of lower measurements of RPT.
引用
收藏
页码:1293 / 1297
页数:5
相关论文
共 21 条
[1]   THE RELATIONSHIP BETWEEN PLEURAL FLUID FINDINGS AND THE DEVELOPMENT OF PLEURAL THICKENING IN PATIENTS WITH PLEURAL TUBERCULOSIS [J].
BARBAS, CSV ;
CUKIER, A ;
DEVARVALHO, CRR ;
BARBAS, JV ;
LIGHT, RW .
CHEST, 1991, 100 (05) :1264-1267
[2]  
BARNES PF, 1990, J IMMUNOL, V145, P149
[3]   TREATMENT OF TUBERCULOSIS AND TUBERCULOSIS INFECTION IN ADULTS AND CHILDREN [J].
BASS, JB ;
FARER, LS ;
HOPEWELL, PC ;
OBRIEN, R ;
JACOBS, RF ;
RUBEN, F ;
SNIDER, DE ;
THORNTON, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (05) :1359-1374
[4]  
CHAN CHS, 1991, RESPIRATION, V58, P171
[5]   CYTOKINE NETWORKS IN THE REGULATION OF INFLAMMATION AND FIBROSIS IN THE LUNG [J].
ELIAS, JA ;
FREUNDLICH, B ;
KERN, JA ;
ROSENBLOOM, J .
CHEST, 1990, 97 (06) :1439-1445
[6]  
FLORES J, 1994, ARCH BRONCONEUMOL S, V30, P38
[7]   RANDOMIZED TRIAL OF CORTICOSTEROIDS IN THE TREATMENT OF TUBERCULOUS PLEURISY [J].
GALARZA, I ;
CANETE, C ;
GRANADOS, A ;
ESTOPA, R ;
MANRESA, F .
THORAX, 1995, 50 (12) :1305-1307
[8]   POTENTIAL THERAPEUTIC INITIATIVES FOR FIBROGENIC LUNG-DISEASES [J].
GOLDSTEIN, RH ;
FINE, A .
CHEST, 1995, 108 (03) :848-855
[9]   Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis [J].
Law, K ;
Weiden, M ;
Harkin, T ;
TchouWong, KM ;
Chi, CX ;
Rom, WN .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (02) :799-804
[10]   CORTICOSTEROIDS IN THE TREATMENT OF TUBERCULOUS PLEURISY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY [J].
LEE, CH ;
WANG, WJ ;
LAN, RS ;
TSAI, YH ;
CHIANG, YC .
CHEST, 1988, 94 (06) :1256-1259